Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 91,499 $ 168,733
Accounts receivable, net 165,516 220,284
Inventory, net 49,333 47,228
Other current assets and prepaid expenses 37,113 47,356
Total current assets 343,461 483,601
Property, plant and equipment, net 146,557 122,831
Intangible assets, net 683,835 763,976
In-process research and development 647,347 644,713
Goodwill 717,099 704,603
Investments 40,642 41,139
Other assets 5,615 5,756
Total assets 2,584,556 2,766,619
Current liabilities:    
Accounts payable 74,307 53,360
Accrued expenses 215,102 197,955
Current portion of lines of credit and notes payable 11,926 11,981
Total current liabilities 301,335 263,296
2033 Senior Notes, net of discount 29,160 43,701
Deferred tax liabilities, net 148,729 165,331
Other long-term liabilities, principally deferred revenue, contingent consideration and lines of credit 219,954 202,483
Total long-term liabilities 397,843 411,515
Total liabilities 699,178 674,811
Equity:    
Common Stock - $0.01 par value, 750,000,000 shares authorized; 560,023,745 and 558,576,051 shares issued at December 31, 2017 and 2016, respectively 5,600 5,586
Treasury Stock, at cost - 549,907 and 586,760 shares at December 31, 2017 and 2016, respectively (1,791) (1,911)
Additional paid-in capital 2,889,256 2,845,096
Accumulated other comprehensive income (loss) (528) (27,009)
Accumulated deficit (1,007,159) (729,954)
Total shareholders’ equity 1,885,378 2,091,808
Total liabilities and equity $ 2,584,556 $ 2,766,619